Hemostasis Harmony

Hemostasis Harmony is a leading consultancy firm dedicated to providing expert guidance and specialized knowledge in the critical areas of hemostasis, coagulation, and platelet biology. With a strong foundation in transfusion medicine and rare blood disorders, including sickle cell diseases and hemophilia, Hemostasis Harmony supports innovation and progress in biotechnology research. Hemostasis Harmony’s consultants bring together extensive experience from global involvement in academia, the pharmaceutical sector, and entrepreneurial ventures, ensuring clients receive insights that are both cutting-edge and practical.

Located in Geneva, CH, Hemostasis Harmony offers comprehensive industry guidance on targets, biomarkers, and active pharmaceutical ingredients (APIs) with the potential to significantly impact the coagulation process. With expertise in coagulation and inflammation cross-talk, Hemostasis Harmony helps clients address safety and adverse event concerns effectively. The team also provides detailed project analysis, including grant and Investigational New Drug (IND) applications, and assists in the development of assays to ensure data relevance and accuracy.

With a profound understanding of translational science, Hemostasis Harmony is adept at interpreting data across various species and matrices, from whole blood to purified systems. Hemostasis Harmony leads projects in target identification and validation, biomarker identification, potency and efficacy assays, and biomarker assay development and validation. Hemostasis Harmony is dedicated to advancing hemostasis research and biotechnology innovation. We invite the manager of Hemostasis Harmony to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.